Lipocalin-2 Is Induced by Uromodulin Aggregates without Affecting Kidney Disease Progression in Autosomal Dominant Tubulointerstitial Kidney Disease–UMOD

Lake, Jennifer;Mariniello, Marta;Schiano, Guglielmo;Guo, Qin;Devuyst, Olivier;et.al.
(2026) Journal of the American Society of Nephrology — (2026)

Files

lipocalin_2_is_induced_by_uromodulin_aggregates.967.pdf
  • Open Access
  • Adobe PDF
  • 2.45 MB

Details

Authors
  • Lake, Jenniferorcid-logoMechanisms of Inherited Kidney Disorders Group, Institute of Physiology, University of Zurich, Zurich, Switzerland
    Author
  • Mariniello, Martaorcid-logoMechanisms of Inherited Kidney Disorders Group, Institute of Physiology, University of Zurich, Zurich, Switzerland
    Author
  • Schiano, Guglielmoorcid-logoMechanisms of Inherited Kidney Disorders Group, Institute of Physiology, University of Zurich, Zurich, Switzerland
    Author
  • Guo, QinMechanisms of Inherited Kidney Disorders Group, Institute of Physiology, University of Zurich, Zurich, Switzerland
    Author
  • Devuyst, Olivierorcid-logoMechanisms of Inherited Kidney Disorders Group, Institute of Physiology, University of Zurich, Zurich, Switzerland
    Author
Show more
Abstract
Key Points c Lipocalin-2 upregulation paralleled intracellular uromodulin aggregates in mouse and cellular models of autosomal dominant tubulointerstitial kidney disease because of pathogenic uromodulin. c The induction of lipocalin-2 was triggered by mutant uromodulin accumulation and endoplasmic reticulum stress in tubular cells. c Genetic loss of lipocalin-2 reduced iron deposits in the kidney but did not affect kidney damage, indicating that lipocalin-2 was not driving disease progression. Abstract Background Autosomal dominant tubulointerstitial kidney disease due to pathogenic UMOD variants (ADTKD-UMOD) is a toxic proteinopathy caused by intracellular accumulation of mutant uromodulin (UMOD) and endoplasmic reticulum (ER) stress. Lipocalin-2 (LCN2) is an acute phase protein induced by ER stress with context-dependent roles in kidney injury. Methods To examine the role of LCN2 in ADTKD-UMOD, we used Umod knock-in mouse models (C171Y, R186S, C125R), urine samples from affected patients, and mIMCD3 cells expressing wild-type or mutant UMOD. LCN2 expression was assessed by immunoblotting, immunostaining, and ELISA. Autophagy was stimulated with Torin1 to evaluate effects on LCN2 induction. Umod R186S/1 mice were crossed with Lcn2 2/2 mice to determine the impact of LCN2 deficiency on disease progression. Results Robust LCN2 induction was observed in kidneys and urine of Umod R186S/1 , Umod C125R/1 , and Umod C171Y/1 mice, correlating with UMOD aggregates and ER stress severity in thick ascending limb cells. In patients, specific UMOD variants were associated with elevated urinary LCN2. In mIMCD3 cells expressing mutant UMOD (C170Y, R185S), treatment with Torin1 reduced aggregates and attenuated LCN2 induction. Genetic deletion of Lcn2 in Umod R186S/1 mice decreased interstitial iron deposition but did not alter UMOD accumulation, interstitial inflammation, or fibrosis. Conclusions LCN2 was induced by intracellular UMOD aggregates and ER stress in various models of ADTKD-UMOD. Although it influenced iron handling, LCN2 did not drive fibrosis or inflammation, supporting a role as a biomarker of toxic proteinopathy rather than a therapeutic target.
Affiliations

Citations

Lake, J., Mariniello, M., Schiano, G., Guo, Q., Mabillard, H., Sayer, J., Olinger, E., Terzi, F., & Devuyst, O. (2026). Lipocalin-2 Is Induced by Uromodulin Aggregates without Affecting Kidney Disease Progression in Autosomal Dominant Tubulointerstitial Kidney Disease–UMOD. Journal of the American Society of Nephrology. Published. https://doi.org/10.1681/asn.0000001077 (Original work published 2026)